Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureRuifu Chemical Supply Brexpiprazole Intermediates Brexpiprazole CAS 913611-97-9 7-Hydroxyquinolinone CAS 70500-72-0 4-Bromobenzo[b]thiophene CAS 5118-13-8 1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 7-(4-Chlorobutoxy)quinolin-2(1H)-one CAS 913613-82-8 4-Chlorobenzo[b]thiophene CAS 66490-33-3| Item | Specifications |
| Appearance | White to Yellow Solid |
| Purity / Analysis Method | >98.0% (HPLC) |
| Infrared Spectrum | Conforms to Structure |
| Proton NMR Spectrum | Conforms to Structure |
| Loss on Drying | <1.00% |
| Heavy Metals | <0.002% |
| Total Impurities | <2.0% |
| Shelf Life | 2 Years |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Brexpiprazole (CAS: 913611-97-9) |
Description:
Specifications:
Package & Storage:
| Chemical Name | 7-Hydroxyquinolinone |
| Synonyms | 2,7-Dihydroxyquinoline; 7-Hydroxy-1,2-Dihydroquinolin-2-one; 7-Hydroxyquinolin-2(1H)-one; 3,4-Dihydro-7-Hydroxycarbostyril; 7-Hydroxycarbostyril |
| CAS Number | 70500-72-0 |
| CAT Number | RF-PI1979 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H7NO2 |
| Molecular Weight | 161.16 |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
7-Hydroxyquinolinone (CAS: 70500-72-0) is a substituted carbostyril derivative as pharmaceutical intermediate. 7-Hydroxyquinolinone is an intermediate of Brexpiprazole (CAS: 913611-97-9). Brexpiprazole is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders. Brexpiprazole is a kind of atypical antipsychotic. It is a dopamine D2 receptor partial agonist. As a novel serotonin-dopamine activity modulator, Brexpiprazole can be used for the treatment of schizophrenia, and for the adjunctive treatment for depression. Brexpiprazole can also provide efficacy and tolerability over established adjunctive treatments formajor depressive disorder (MDD). Recent study has also suggested Brexpiprazole can ameliorate PCP-induced cognitive deficits in mice via 5-HT1A receptors.
